Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Anne Valente MD
Anne Marie Valente MD Advisory Board
Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI
Deepak L. Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI Advisory Board
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI
J. William McEvoy MB BCh BAO, MEd, MHS, PhD, FRCPI Advisory Board
See All Experts
featured
Published in Cardiology and
1 other channel

Journal Scan / Research · January 05, 2017

Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial

Diabetes Care

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

David Cherney MD, PhD

Benjamin Scirica MD

Diabetes Care
Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial
Diabetes Care 2017 Jan 01;40(1)69-76, O Mosenzon, G Leibowitz, DL Bhatt, A Cahn, B Hirshberg, C Wei, K Im, A Rozenberg, I Yanuv, C Stahre, KK Ray, N Iqbal, E Braunwald, BM Scirica, I Raz

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated